Funder: Pfizer Inc.

Due Dates: June 11, 2026 (Submission deadline for full application)

Funding Amounts: Up to $250,000 per project; total estimated budget $500,000; max project duration 18 months.

Summary: Supports independent medical education initiatives to improve community healthcare professionals’ knowledge and competence in managing relapsed/refractory large B-cell lymphoma.

Key Information: Only organizations (not individuals) may apply; projects must be educational, not clinical research.